N/A
Completed N=78
Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease
Source: ClinicalTrials.gov NCT04738474 ↗Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcomePrimary: Feasibility of Enrollment — 40; 38 Participants
Summary
The purpose of this study is to evaluate the feasibility and preliminary efficacy of the Promoting Resilience in Stress Management (PRISM) intervention in patients with adult congenital heart disease.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Enrollment |
40; 38 | — |
| PRIMARY Feasibility of PRISM |
32; 35 | — |
| SECONDARY Mean Resilience |
30.1; 28.7 | — |
Eligibility Criteria
Inclusion Criteria
- adults with moderate or complex ACHD, stages B, C, or D as defined by the 2018 ACHD guidelines
- receive care in our health system
Exclusion Criteria
- diagnosis of another life-limiting illness
- inability to participate in study activities independently and in English
Data sourced from ClinicalTrials.gov (NCT04738474). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.